![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/08 | (2006.01) |
A61K 38/26 | (2006.01) | ||
C07K 14/605 | (2006.01) | ||
A61K 39/395 | (2006.01) | ||
A61K 47/12 | (2006.01) | ||
A61K 47/26 | (2006.01) | ||
A61K 9/00 | (2006.01) | ||
A61K 47/10 | (2017.01) | ||
A61K 38/22 | (2006.01) | ||
A61K 47/68 | (2017.01) |
(11) | Number of the document | 3610856 |
(13) | Kind of document | T |
(96) | European patent application number | 19180160.4 |
Date of filing the European patent application | 2013-11-06 | |
(97) | Date of publication of the European application | 2020-02-19 |
(45) | Date of publication and mention of the grant of the patent | 2021-08-18 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
20120124725 | 2012-11-06 | KR |
(72) |
KIM, Hyun Uk , KR
LIM, Hyung Kyu , KR
JANG, Myung Hyun , KR
KIM, Sang Yun , KR
BAE, Sung Min , KR
KWON, Se Chang , KR
|
(73) |
Hanmi Pharm. Co., Ltd. ,
214 Muha-ro
Paltan-myeon, Hwaseong-si, Gyeonggi-do 445-958,
KR
|
(54) | LIQUID FORMULATION OF PROTEIN CONJUGATE COMPRISING THE OXYNTOMODULIN AND AN IMMUNOGLOBULIN FRAGMENT |
LIQUID FORMULATION OF PROTEIN CONJUGATE COMPRISING THE OXYNTOMODULIN AND AN IMMUNOGLOBULIN FRAGMENT |